Skip to content

Native Alignment in the Setting of an Arthritic Knee in Total Knee Arthroplasty

Native Alignment in the Setting of an Arthritic Knee in Total Knee Arthroplasty

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06617338
Enrollment
1
Registered
2024-09-27
Start date
2024-12-12
Completion date
2026-03-02
Last updated
2026-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis (OA) of the Knee

Keywords

osteoarthritis, knee, total knee arthroplasty, target alignment

Brief summary

The goal of this clinical trial is to learn if preparing the target alignment of the operative side in total knee arthroplasty (TKA) based on the non-arthritic side will give the patient better overall alignment, function, and improved results compared to basing our implant alignment and positioning off the arthritic side, which is currently the traditional method. The main questions it aims to answer are: * Will a patient have improved postoperative TKA results if the implant alignment is based off the non-arthritic side compared to the standard arthritic side? * What are the similarities or differences between study arms with respect to final implant alignment and positioning angles? Researchers will compare the outcomes of two cohorts of patients undergoing primary robotic-assisted total knee arthroplasty (RA-TKA) with normal contralateral knee. Based on preoperative CT imaging, the researchers will use normal contralateral side joint numbers as the target alignment for one group (Experimental arm) and utilize the traditional method for the other group (Active comparator arm). Clinical outcomes and patient-reported outcome measures (PROMs) will be compared between groups. Participants will: * Be randomized into one of two study arms and will receive either a unilateral knee CT or bilateral knee CT preoperatively * Follow-up in the clinic at 2 weeks, 6 weeks and 1-year postoperatively, per standard-of-care for x-ray and clinical evaluation. * Complete postop questionnaires (PROMs) at the prescribed follow-up intervals

Interventions

DIAGNOSTIC_TESTCT scan unilateral knee

Intervention given to the Active Comparator arm

DIAGNOSTIC_TESTCT scan bilateral knee

Intervention given to the Experimental Arm

Sponsors

University of Louisville
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Prospective, randomized cohort analysis study

Eligibility

Sex/Gender
ALL
Age
21 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

1. Patient age is 21-89 at time of surgery 2. Patient is indicated to undergo a unilateral primary TKA, secondary to osteoarthritis 3. Patient's contralateral knee is non-arthritic 4. Patient agrees to participate as a study subject and signs the Informed Consent and Research Authorization document 5. Patient is able to read and speak English.

Exclusion criteria

1. Patient is under the age of 21 2. Patient's primary diagnosis is not osteoarthritis 3. Patient is unable to read and speak English 4. History of previous DVT/PE 5. History of stroke, CABG, or A fib 6. Current smoker

Design outcomes

Primary

MeasureTime frameDescription
Overall Satisfaction1-year postoperativelyOverall Satisfaction with TKA using a Likert scale
Pain VASpreoperatively, 6 weeks (± 2 weeks), and 1-year postoperativelyLevel of knee pain (scale of zero to ten) using the Visual Analog Scale (VAS)
KOOS JRpreoperatively, 6 weeks (± 2 weeks), and 1-year postoperativelyKOOS JR questionnaire
Forgotten Joint Scorepreoperatively, 6 weeks (± 2 weeks), and 1-year postoperativelyFJS-12 questionnaire
PROMIS-10 Mental and Physical Health scorespreoperatively and 1-year postoperativelyPROMIS-10 Global Health questionnaire
Incidence of revision TKA1 year postoppostoperative complication requiring a revision total knee arthroplasty
non-revision complication1 year postoppostoperative complication requiring a non-revision procedure

Secondary

MeasureTime frameDescription
Active ROMpreoperatively, 6 weeks (± 2 weeks), and 1-year postoperativelyActive knee range of motion: active extension, active flexion

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026